US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Drugs Made in America Acquisition Corp. II

10.02

-0.0100-0.10%

Volume:1.74K

Turnover:17.43K

Market Cap:657.06M

PE:- -

High:10.03

Open:10.02

Low:10.02

Close:10.03

52wk High:10.06

52wk Low:9.94

Shares:65.58M

Float Shares:50.00M

Volume Ratio:0.01

T/O Rate:0.00%

Dividend:- -

Dividend Rate:- -

ROE:--

ROA:--

PB:-5629.43

PE(LYR):- -

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

Drugs Made in America Acquisition II Corp. Begins Separate Trading of Shares and Rights

Drugs Made in America Acquisition II Corp. Appoints Saleem Elmasri as Chief Financial Officer

Drugs Made in America Acquisition II Corp. Delays Quarterly Report Filing

Audit Report Released for Drugs Made in America Acquisition II Corp.’s Financial Statements

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/DMIIU"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"DMIIU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"DMIIU\",,,,,undefined,":{"symbol":"DMIIU","market":"US","secType":"STK","nameCN":"Drugs Made in America Acquisition Corp. II","latestPrice":10.02,"timestamp":1764968400000,"preClose":10.03,"halted":0,"volume":1739,"delay":0,"floatShares":50000000,"shares":65575000,"eps":0,"marketStatus":"Market Closed","change":-0.01,"latestTime":"12-05 16:00:00 EST","open":10.02,"high":10.03,"low":10.02,"amount":17430.695,"amplitude":0.000997,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1765184400000},"marketStatusCode":7,"adr":0,"listingDate":1758772800000,"exchange":"NASDAQ","adjPreClose":10.03,"preHourTrading":{"tag":"盘前","latestPrice":10.02,"preClose":10.025,"latestTime":"09:28 EST","volume":200,"amount":2004,"timestamp":1764944884299},"volumeRatio":0.013603090148609744},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"DMIIU\",,,,,undefined,":{"symbol":"DMIIU","floatShares":50000000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.013603090148609744,"shares":65575000,"dividePrice":0,"high":10.03,"amplitude":0.000997,"preClose":10.03,"low":10.02,"week52Low":9.935,"pbRate":"-5629.43","week52High":10.06,"institutionHeld":0,"latestPrice":10.02,"eps":0,"divideRate":0,"volume":1739,"delay":0,"ttmEps":0,"open":10.02,"prevYearClose":9.98,"prevWeekClose":10.015,"prevMonthClose":10.015,"prevQuarterClose":9.945,"fiveDayClose":10.015,"twentyDayClose":10.035},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/DMIIU\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"DMIIU\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"DMIIU\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"DMIIU\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2588048767","title":"Drugs Made in America Acquisition II Corp. Begins Separate Trading of Shares and Rights","url":"https://stock-news.laohu8.com/highlight/detail?id=2588048767","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588048767?lang=en_us&edition=fundamental","pubTime":"2025-12-03 19:34","pubTimestamp":1764761648,"startTime":"0","endTime":"0","summary":"Drugs Made in America Acquisition II Corp., a special purpose acquisition company, announced that starting December 3, 2025, investors who purchased units in its initial public offering can now separately trade the company's ordinary shares and rights on the Nasdaq Global Market. The ordinary shares will trade under the symbol \"DMII\" and the rights under \"DMIIR.\" Units that remain combined will continue to trade under \"DMIIU.\" Investors wishing to separate their units must coordinate with their brokers and the company's transfer agent, Continental Stock Transfer & Trust Company.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Drugs Made in America Acquisition II Corp. published the original content used to generate this news brief via G","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251203:nNDL9ZgSCv:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0314104364.USD","LU2210149790.SGD","BK4112","IE00BGHQF748.EUR","IE00BKPKM429.USD","LU2095319765.USD","IE00B64PRP62.GBP","BK4585","BK4588","DMIIU","NDAQ","LU2210150020.SGD","IE00B3QW5Z07.USD"],"gpt_icon":0},{"id":"2584393249","title":"Drugs Made in America Acquisition II Corp. Appoints Saleem Elmasri as Chief Financial Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2584393249","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584393249?lang=en_us&edition=fundamental","pubTime":"2025-11-18 19:03","pubTimestamp":1763463789,"startTime":"0","endTime":"0","summary":"Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Drugs Made in America Acquisition II Corp. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on November 18, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251118:nNDLbW3RLx:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DMIIU"],"gpt_icon":0},{"id":"2584476046","title":"Drugs Made in America Acquisition II Corp. Delays Quarterly Report Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2584476046","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584476046?lang=en_us&edition=fundamental","pubTime":"2025-11-17 19:30","pubTimestamp":1763379032,"startTime":"0","endTime":"0","summary":"Drugs Made in America Acquisition II Corp. has disclosed a delay in filing its quarterly financial report on Form 10-Q for the period ended September 30, 2025. The company filed a notification of late filing and expects to submit the report within the allowed extension period.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Drugs Made in America Acquisition II Corp. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on November 17, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251117:nNDL7qPCsj:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DMIIU"],"gpt_icon":0},{"id":"2572652595","title":"Audit Report Released for Drugs Made in America Acquisition II Corp.’s Financial Statements","url":"https://stock-news.laohu8.com/highlight/detail?id=2572652595","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572652595?lang=en_us&edition=fundamental","pubTime":"2025-10-03 05:15","pubTimestamp":1759439758,"startTime":"0","endTime":"0","summary":"Drugs Made in America Acquisition II Corp. has published its audit report for the financial statements as of September 26, 2025. The report was issued by MaloneBailey, LLP. The full report can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Drugs Made in America Acquisition II Corp. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on October 02, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251002:nNDL55XsGW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DMIIU"],"gpt_icon":0}],"pageSize":4,"totalPage":3,"pageCount":1,"totalSize":9,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/DMIIU\",params:#limit:6,delay:false,,,undefined,":[]}}